RE-DUAL PCI

Document ID: PC-ZA-100416

01/06/2018

Author: Boehringer Ingelheim


Open-label trial evaluating antithrombotic therapy in patients with AF undergoing PCI

123,000
Views

100k 340

Production date: May 2019